InMed Pharmaceuticals, Inc. (INM)
1.305
+0.02
(+1.16%)
USD |
NASDAQ |
Sep 14, 16:00
1.305
0.00 (0.00%)
After-Hours: 16:59
InMed Pharmaceuticals Market Cap : 6.968M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.888M |
| September 10, 2026 | 6.995M |
| September 09, 2026 | 6.995M |
| September 08, 2026 | 7.101M |
| September 04, 2026 | 4.574M |
| September 03, 2026 | 4.408M |
| September 02, 2026 | 4.474M |
| September 01, 2026 | 4.375M |
| August 31, 2026 | 4.474M |
| August 28, 2026 | 4.574M |
| August 27, 2026 | 4.739M |
| August 26, 2026 | 4.739M |
| August 25, 2026 | 4.772M |
| August 24, 2026 | 4.739M |
| August 21, 2026 | 4.839M |
| August 20, 2026 | 5.236M |
| August 19, 2026 | 5.269M |
| August 18, 2026 | 4.772M |
| August 17, 2026 | 4.839M |
| August 14, 2026 | 4.872M |
| August 13, 2026 | 4.739M |
| August 12, 2026 | 4.772M |
| August 11, 2026 | 4.839M |
| August 10, 2026 | 4.673M |
| August 07, 2026 | 4.872M |
| Date | Value |
|---|---|
| August 06, 2026 | 4.739M |
| August 05, 2026 | 4.640M |
| August 04, 2026 | 4.938M |
| August 03, 2026 | 4.839M |
| July 31, 2026 | 4.872M |
| July 30, 2026 | 4.971M |
| July 29, 2026 | 5.534M |
| July 28, 2026 | 5.534M |
| July 27, 2026 | 5.435M |
| July 24, 2026 | 5.667M |
| July 23, 2026 | 6.131M |
| July 22, 2026 | 5.501M |
| July 21, 2026 | 5.104M |
| July 20, 2026 | 5.037M |
| July 17, 2026 | 5.037M |
| July 16, 2026 | 5.269M |
| July 15, 2026 | 5.269M |
| July 14, 2026 | 5.17M |
| July 13, 2026 | 5.203M |
| July 10, 2026 | 5.435M |
| July 09, 2026 | 5.501M |
| July 08, 2026 | 5.468M |
| July 07, 2026 | 5.534M |
| July 06, 2026 | 5.336M |
| July 02, 2026 | 5.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NervGen Pharma Corp. | 233.04M |
| Milestone Pharmaceuticals, Inc. | 118.34M |
| Clearmind Medicine, Inc. | 0.9376M |
| Lexaria Bioscience Corp. | 5.800M |
| Target Group, Inc. (Canada) | 0.6787M |
Market Cap Related Metrics
| PS Ratio | 2.746 |
| Price to Book Value | 6.482 |
| Price | 1.305 |
| Earnings Yield | -238.8% |